Weiss Asset Management LP Biogen Inc. Transaction History

Weiss Asset Management LP

  • $3.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$212.02 - $267.71 $329,479 - $416,021
1,554 New
1,554 $335,000
Q3 2021

Nov 12, 2021
SELL
$282.99 - $369.05 $1.59 Million - $2.07 Million
-5,612 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$259.0 - $414.71 $1.45 Million - $2.33 Million
5,612 New
5,612 $1.94 Million

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Weiss Asset Management LP Portfolio

Follow Weiss Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Asset Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email